Sanprobi IBS drops 5 ml

The Sanprobi IBS dietary supplement is a high-quality product that contains the unique probiotic bacterial strain Lactobacillus plantarum 299v. It is especially intended for people suffering from irritable bowel syndrome. The product has undergone extensive testing and has been shown to provide many benefits to these individuals. The product has the advantage of being convenient to use in drop form and can be stored at room temperature.

The irritable bowel syndrome (IBS) is a very common functional disorder of the gastrointestinal tract. Its manifestation is not well understood. Therapeutic options are also limited. According to recent studies, probiotics may have an effect on regulating gastrointestinal motility.

The intestinal microflora is significantly altered in IBS[1]. Probiotic preparations can be a good option as antimicrobial agents in the treatment and prevention of intestinal infections. It has been shown that Lactobacillus plantarum 299v inhibits the adhesion of a pathogenic bacterium, Escherichia coli, to intestinal epithelial cells[2].

A study was conducted in which products containing the bacterial strain Lactobacillus plantarum 299v were recommended to patients suffering from irritable bowel syndrome. All patients supplemented with this strain reported cessation of abdominal pain and normalization of stool frequency (those with the constipated form of IBS). Lactobacillus plantarum 299v therefore appears to have a beneficial effect on the condition of patients suffering from irritable bowel syndrome.[3]

In summary, the dietary supplement Sanprobi IBS is a high-quality product that contains the unique probiotic bacterial strain Lactobacillus plantarum 299v. This product is designed to restore the intestinal microflora and support therapy for patients suffering from irritable bowel syndrome.

1 Kassinen A, Krogius-Kurikka L, Mäkivuokko H, Rinttilä T, Paulin L, Corander J, Malinen E, Apajalahti J, Palva A. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology. 2007 Jul;133(1):24-33. doi: 10.1053/j.gastro.2007.04.005. Epub 2007 Apr 14. PMID: 17631127.

2. Mack DR, Michail S, Wei S, McDougall L, Hollingsworth MA. Probiotics inhibit adherence of enteropathogenic E. coli in vitro by inducing expression of the intestinal mucin gene. Am J Physiol. 1999 Apr;276(4):G941-50. doi: 10.1152/ajpgi.1999.276.4.G941. PMID: 10198338.

3 Niedzielin K, Kordecki H, Birkenfeld B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2001 Oct;13(10):1143-7. doi: 10.1097/00042737-200110000-00004. PMID: 11711768.